Medizinische Univ. Wien, Univ.Klinik f. Innere Medizin I, Onkologie
Welcome,         Profile    Billing    Logout  
 11 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Keil, Felix
DIsCOvER, NCT03984214: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Active, not recruiting
3
109
Europe
Dronabinol in Oral Dosage Form, BX-1, Placebo in Oral Dosage Form
Arbeitsgemeinschaft medikamentoese Tumortherapie, Medical University of Graz, Unidata Geodesign, Bionorica SE
Pancreatic Cancer Non-resectable, Chemotherapy-induced Nausea and Vomiting, Pancreatic Cancer Metastatic
09/24
09/24
aMYELOIDr, NCT04438889: Austrian Myeloid Registry

Recruiting
N/A
3000
Europe
Non-interventional
Arbeitsgemeinschaft medikamentoese Tumortherapie
Myeloid Diseases
04/29
04/30
Krauth, Maria-Theresa
NCT04891809: Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Recruiting
2
198
Europe, RoW
Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral
Arbeitsgemeinschaft medikamentoese Tumortherapie, University of Navarra, Medical University of Vienna, Assign Data Management and Biostatistics GmbH, WiSP GmbH, Sanofi
Newly Diagnosed Multiple Myeloma
12/27
12/28
Sliwa, Thamer
PhALLCON, NCT03589326 / 2018-000397-30: A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Checkmark Data from PhALLCON Study for newly diagnosed Ph+ ALL at SOHO 2020
Sep 2019 - Sep 2019: Data from PhALLCON Study for newly diagnosed Ph+ ALL at SOHO 2020
Checkmark Initiation of new trial in Ph+ ALL
Jul 2018 - Jul 2018: Initiation of new trial in Ph+ ALL
Active, not recruiting
3
245
Europe, Canada, Japan, US, RoW
Ponatinib, Iclusig, Imatinib, Gleevec, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Takeda
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
08/22
07/27
DIsCOvER, NCT03984214: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Active, not recruiting
3
109
Europe
Dronabinol in Oral Dosage Form, BX-1, Placebo in Oral Dosage Form
Arbeitsgemeinschaft medikamentoese Tumortherapie, Medical University of Graz, Unidata Geodesign, Bionorica SE
Pancreatic Cancer Non-resectable, Chemotherapy-induced Nausea and Vomiting, Pancreatic Cancer Metastatic
09/24
09/24
NCT04891809: Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Recruiting
2
198
Europe, RoW
Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral
Arbeitsgemeinschaft medikamentoese Tumortherapie, University of Navarra, Medical University of Vienna, Assign Data Management and Biostatistics GmbH, WiSP GmbH, Sanofi
Newly Diagnosed Multiple Myeloma
12/27
12/28
Agis, Hermine
AFFIRM-AL, NCT04973137: A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Recruiting
3
220
Europe, Canada, Japan, US, RoW
Birtamimab, Placebo, Standard of Care Chemotherapy
Prothena Biosciences Ltd.
Light Chain (AL) Amyloidosis
06/25
06/27
Prager, Gerald
No trials found

Download Options